Temazepam and Cyclobenzaprine: Sedation Risks and Safer Alternatives
Combined CNS Depression Risk
Both temazepam (Restoril) and cyclobenzaprine cause central nervous system depression. Using them together increases the risk of excessive sedation, respiratory depression, falls, and impaired driving.
Clinical Recommendations
- Avoid concurrent use if possible.
- If both are necessary, separate dosing (e.g., cyclobenzaprine daytime, temazepam at bedtime) and use the lowest effective doses.
- Monitor for confusion, ataxia, and next‑day impairment.
- Evaluate non‑drug options: CBT‑I for insomnia, physical therapy or less sedating muscle relaxants for spasms.
Always discuss combination therapy with your prescriber and pharmacist.
Prescription Medications - Related Articles
- Cannabis for Glaucoma: Lowers IOP But Not a Standalone Treatment
- Namenda (Memantine): Understanding Risks, Side Effects & Interactions
- Anodyne Therapy: Relief for Peripheral Neuropathy
- Blakoe Ring: A Safe & Effective Alternative for Erectile Dysfunction
- Valtrex Interactions: What to Avoid & Potential Conflicts
- Dramamine: Dosage, Uses & Motion Sickness Relief
- Ketoconazole Treatment Duration: What You Need to Know
